Literature DB >> 23009222

Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer.

Megumi Takeuchi1, Tomoharu Sugie, Kassim Abdelazeem, Hironori Kato, Nobuhiko Shinkura, Masahiro Takada, Hiroyasu Yamashiro, Takayuki Ueno, Masakazu Toi.   

Abstract

The indocyanine green fluorescence (ICGf) navigation method provides real-time lymphatic mapping and sentinel lymph node (SLN) visualization, which enables the removal of SLNs and their associated lymphatic networks. In this study, we investigated the features of the drainage pathways detected with the ICGf navigation system and the order of metastasis in axillary nodes. From April 2008 to February 2010, 145 patients with clinically node-negative breast cancer underwent SLN surgery with ICGf navigation. The video-recorded data from 79 patients were used for lymphatic mapping analysis. We analyzed 145 patients with clinically node-negative breast cancer who underwent SLN surgery with the ICGf navigation system. Fluorescence-positive SLNs were identified in 144 (99%) of 145 patients. Both single and multiple routes to the axilla were identified in 47% of cases using video-recorded lymphatic mapping data. An internal mammary route was detected in 6% of the cases. Skip metastasis to the second or third SLNs was observed in 6 of the 28 node-positive patients. We also examined the strategy of axillary surgery using the ICGf navigation system. We found that, based on the features of nodal involvement, 4-node resection could provide precise information on the nodal status. The ICGf navigation system may provide a different lymphatic mapping result than computed tomography lymphography in clinically node-negative breast cancer patients. Furthermore, it enables the identification of lymph nodes that do not accumulate indocyanine green or dye adjacent to the SLNs in the sequence of drainage. Knowledge of the order of nodal metastasis as revealed by the ICGf system may help to personalize the surgical treatment of axilla in SLN-positive cases, although additional studies are required.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23009222     DOI: 10.1111/tbj.12004

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  15 in total

1.  Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.

Authors:  Funda Meric-Bernstam; John C Rasmussen; Savitri Krishnamurthy; I-Chih Tan; Banghe Zhu; Jamie L Wagner; Gildy V Babiera; Elizabeth A Mittendorf; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2013-12-13       Impact factor: 3.732

2.  Near-infrared fluorescence sentinel lymph node mapping in breast cancer: a multicenter experience.

Authors:  Floris P R Verbeek; Susan L Troyan; J Sven D Mieog; Gerrit-Jan Liefers; Lorissa A Moffitt; Mireille Rosenberg; Judith Hirshfield-Bartek; Sylvain Gioux; Cornelis J H van de Velde; Alexander L Vahrmeijer; John V Frangioni
Journal:  Breast Cancer Res Treat       Date:  2013-12-13       Impact factor: 4.872

3.  Surgical Management of the Axilla in Breast Cancer Patients with Negative Sentinel Lymph Node: A Method to Reduce False-Negative Rate.

Authors:  Qianqian Yuan; Gaosong Wu; Shu-Yuan Xiao; Yukun He; Kun Wang; Dan Zhang
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 4.  A review of performance of near-infrared fluorescence imaging devices used in clinical studies.

Authors:  B Zhu; E M Sevick-Muraca
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

5.  ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes in Breast Cancer: Results of a Prospective Open-label Clinical Trial.

Authors:  E-M Grischke; C Röhm; M Hahn; G Helms; S Brucker; D Wallwiener
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

6.  Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye.

Authors:  Wenbin Guo; Li Zhang; Jun Ji; Wei Gao; Jintao Liu; Meng Tong
Journal:  Tumour Biol       Date:  2013-12-05

7.  Dynamic fluorescent imaging with indocyanine green for monitoring the therapeutic effects of photoimmunotherapy.

Authors:  Towhid Ali; Takahito Nakajima; Kohei Sano; Kazuhide Sato; Peter L Choyke; Hisataka Kobayashi
Journal:  Contrast Media Mol Imaging       Date:  2014 Jul-Aug       Impact factor: 3.161

Review 8.  Current status of optical imaging for evaluating lymph nodes and lymphatic system.

Authors:  Eun Seong Lee; Tae Sung Kim; Seok-Ki Kim
Journal:  Korean J Radiol       Date:  2015-01-09       Impact factor: 3.500

9.  Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.

Authors:  Jennifer L Baker; Minya Pu; Christopher A Tokin; Carl K Hoh; David R Vera; Karen Messer; Anne M Wallace
Journal:  Ann Surg Oncol       Date:  2014-07-29       Impact factor: 5.344

10.  Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.

Authors:  Wenbin Guo; Li Zhang; Jun Ji; Wei Gao; Jintao Liu; Meng Tong
Journal:  World J Surg Oncol       Date:  2014-09-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.